Cost-effectiveness analysis of 3 different drugs in the treatment of type 2 diabetes mellitus
10.3760/cma.j.issn.1008-6706.2012.03.018
- VernacularTitle:2型糖尿病三种治疗方案的成本-效果分析
- Author:
Yanqin TANG
- Publication Type:Journal Article
- Keywords:
Diabetes mellitus,type 2;
Clinical protocols;
Fees,pharmaceutical
- From:
Chinese Journal of Primary Medicine and Pharmacy
2012;19(3):355-356
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the cost-effectiveness of the treatment of type 2 diabetes by 3 different drugs.Methods Through the retrospective analysis of 198 cases with T2DM and drug economics,to analyze the costeffectiveness of the Yamo Li(glimepiride),repaglinide(repaglinide) and Avandia(rosiglitazone).Results No significant difference was observed in the total effective rate among the 3 drugs.The cost-effectiveness ratios in Group A,B and C were 2.99,1.43 and 5.76.The cost-effectiveness ratios increments in Group A,B and C were 42.15,18.32 and 214.74.Conclusion Based on individual differences of the patients,doctor should choose the drug with best treatment,lowest price and highest safety.
